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ABSTRACT 
THE ROLE OF CHMP1 IN DROSOPHILA MELANOGASTER 
 
Meagan E. Valentine 
 
Chmp1A has recently been linked to pancreatic cancer, a leading cause of cancer 
death in humans.  Pancreatic tumors have lowered Chmp1A expression, and it has been 
described as a tumor suppressor. Chmp1A is also a member of ESCRT III (Endosomal 
Sorting Complex Required for Transport), a conserved protein complex involved in the 
degradation and recycling of activated transmembrane receptors. There is a single Chmp1 
protein in Drosophila that is homologous to vertebrate Chmp1A; however, Chmp1 hasn’t 
been studied in Drosophila. The objective of this study was to characterize Chmp1 in 
Drosophila using gene knockdown and over-expression. We used an RNAi fly line to 
knockdown Chmp1 in the wing of the fly and created a transgenic fly line to look at over-
expression. Our results suggest that Chmp1 may be regulating the Epidermal Growth 
Factor pathway and Notch-Delta signaling, as well as the Frizzled-Planar Cell Polarity 
pathway. 
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BACKGROUND 
 
i. ESCRT 
Many proteins in the cell membrane, such as ion channels and receptors, are 
constantly fluctuating; these proteins can be endocytosed, and then recycled or degraded. 
The ESCRT complexes (Endosomal Sorting Complex Required for Transport 0, I, II, III) 
play a role in a major pathway used for the targeted degradation of transmembrane 
receptor proteins. These complexes are required for control of cell signaling, down 
regulation of receptors, as well as other normal and pathological cell processes (1, 2, 3). 
In this pathway, activated receptor proteins are usually targeted for degradation by 
monoubiquitination. They are then endocytosed and transported to the early endosome 
(4). At the early endosome, proteins are sorted into multivesicular bodies (MVBs), which 
fuse to the lysosome and are degraded (5, 6). This makes the MVBs very important for 
receptor down regulation (7). The MVBs are also important for intercellular 
communication and antigen presentation, as they are also able to fuse with the plasma 
membrane, expelling their contents into the extracellular matrix (8, 9, 10). This pathway 
is highly conserved in eukaryotic organisms. 
 At least eleven proteins in mammals have been identified as components of 
ESCRT-III and are collectively referred to as charged multivesicular proteins (Chmps) (1, 
2). All of these Chmps have similar characteristics: they are about 200 amino acids long, 
contain a coiled-coil region and charged residues, and they have a basic N-terminus and 
an acidic C-terminus (Figure 1) (1, 2). 
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Figure 1. Chmp protein structure.  
 
Chmps are rather small proteins about 200 amino acids in length with a basic N-terminus, 
an acidic C-terminus, and a coiled-coil (CC) domain. 
 
ii. Chmp1A  
 Chmp1A is a highly conserved protein in both complex and simple eukaryotes. In 
different organisms it is known by several different names: Chmp1
1
 (Chromatin 
Modifying Protein1), Chmp1A
2
 (Charged Multivesicular Protein1), VPS46p/Did2p
3
, and 
Sal1
4
 (Supernumerary Aleurone Layers 1) (4, 11, 12, 13). In humans, there are two 
different isoforms of Chmp1A: a 35 kDa Chmp1A, which localizes to the nucleus, and a 
32 kDa Chmp1A, which is located in the cytoplasm (11). The functional and structural 
differences between these two Chmp1A species are most likely due to differential post-
translational modification.  
It has been shown that the larger and nuclear form of Chmp1A is tightly 
associated with the nuclear matrix and has been suggested to play a role in stable gene 
silencing within the nucleus (13). In the nucleus, Chmp1A is associated with condensed 
chromatin and it has been reported that Chmp1A affects nuclear structure by increasing 
nuclear DNA concentration through chromatin condensation (13). Over-expression of 
                                               
1
 Drosophila melanogaster – NP_649051/CG4108 
2
 Homo sapiens – NM_002768, this is a variant of Chmp1. There is also a Chmp1B  
3
 Saccharomyces cerevisiae – NP_012961 
4
 Zea mays - NP_00110521 
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Chmp1A affects DNA replication by halting cells in the S-phase of the cell cycle, 
possibly by way of its effects on chromatin structure (13). Chmp1A was also found to 
physically interact with the Polycomblike (Pcl) protein, and to recruit BMI1 protein, both 
of which are members of the Polycomb group (PcG) of transcriptional repressors 
responsible for gene silencing during development (13, 14, 15).   
The cytoplasmic form of Chmp1A is a member of the ESCRT-III complex. 
Chmp1A localizes at the early and late endosomes, where it is involved in protein sorting 
and MVB formation (11).  The Chmp1A protein has also been shown to bind to the VPS4 
protein, which is shown to mediate the ATP-dependant disassociation of the ESCRT 
complexes and complete MVB formation (2, 11).   
Loss of function of several the ESCRT components has been shown to give rise to 
over-proliferative phenotypes that are probably a consequence of failure of protein 
sorting. In Drosophila, genetic defects in Vps25 activity cause loss of cell polarity in 
epithelial tissue, followed by cell over-proliferation (16, 17). Tsg101, the mammalian 
homologue of Vps23 induces cell transformation and tumor formation in mice (2, 18, 19). 
Also, HCRP1, the human homologue of Vps37 is associated with hepatocellular 
carcinoma (HCC) (20, 21). In addition, mutations in the sal1 gene, the maize homologue 
of Chmp1A, cause multiple layers of aleurone cells to form, a phenotype which may 
attributed to problematic receptor degradation (12). As a component of ESCRT, Chmp1A 
may be important for the control of cell growth by participating in the regulation of 
membrane receptor and signaling proteins. 
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iii. Pancreatic Cancer 
Chmp1A has been linked to pancreatic cancer in humans (22). Pancreatic cancer 
is a leading cause of cancer death, with a five-year survival rate of only four percent.  The 
mortality associated with pancreatic cancer is due to its aggressive malignancy, its high 
resistance to treatment, and that it is often not diagnosed until it is quite advanced (23). 
Although much research is in progress, still little is known about its molecular 
pathogenesis. However, specific patterns of expression have been identified and 
associated with pancreatic adenocarcinomas. Mutations in several genes, including 
KRAS, are characteristic of the disease (24). KRAS is a member of the RAS family 
oncogenes, of which activating mutations cause over-proliferation and cell survival (24). 
KRAS mutations are present in nearly 100% of adenocarcinomas (24).  
 
iv. Drosophila as a Model 
 In this study, Drosophila melanogaster was used as a model for studying Chmp1 
activity. Drosophila is a model organism that is often used for studying the function of 
human proteins. This species has a rather short generation time, is easy to work with, has 
elegant genetics, and it is inexpensive; all of these characteristics make Drosophila a 
good model. Additionally, the Drosophila genome has been sequenced, providing an 
important resource to biologists and identifying over 13,000 genes. There has also been 
over 100 years of work on Drosophila, which provides researchers with an extensive base 
of knowledge of this species (Flybase). There are many sophisticated genetic and 
molecular tools that have been developed for studying gene and protein function, many of 
which are unique to this organism. However, probably most importantly, there is a great 
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deal of homology between human genes and Drosophila genes. Of about 300 known 
human disease genes, almost 200 have homologues in Drosophila (25). We also share 
common pathways, making many of the results in Drosophila transferable. 
 There have been no published studies of Chmp1 function in Drosophila and our 
knowledge of vertebrate Chmp1A is incomplete. It is known that there is only one copy 
of Chmp1 in Drosophila, which will make it easier to study because we will not have to 
worry about the activity of homologous gene products. From previous work in the Collier 
lab, it is also known that Chmp1 is expressed in all embryonic tissues. Probably most 
importantly, we know that the protein sequence of Drosophila Chmp1 is 49% identical to 
Chmp1A in humans, allowing for the conclusions drawn about Drosophila Chmp1 
function to be applicable to Chmp1A function in humans. 
 
v. UAS-Gal4 System 
 The UAS-Gal4 system (Figure 2) is a sophisticated genetic tool that is widely 
used in Drosophila studies (26). It was first identified in yeast, but has been modified and 
is now used in other systems, including Drosophila and mammalian cell culture. This 
system allows for very fine control of the location and the intensity that a gene of interest 
will be expressed. When a transgene is under the control of a UAS (Upstream Activating 
Sequence) promoter, it will only be expressed in the presence of Gal4. Conveniently, 
there are thousands of fly lines that have been designed to express Gal4 in specific areas 
of the fly, at different intensities, and sometimes at specific times during development. 
This makes controlling gene expression quite easy, as with a single generation cross you 
can knock down or over-express a gene where you choose and to the extent you choose. 
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This efficacy of this system is temperature related, with 30
o
C producing strongest 
expression. There is higher UAS-Gal4 activity in a fly line at 30
o
C than the same fly line 
at 18
o
C, and therefore a stronger phenotype is exhibited (27). 
 
 
 
 
 
 
 
 
 
 
vi. Drosophila Wing Anatomy 
The Drosophila wing (Figure 3) is like a flattened balloon. It has a dorsal and a 
ventral side that oppose each other, each one cell-layer thick. Cuticular structures called 
veins are distributed in a distinctive pattern, contributing rigidity to the wing. The pattern 
of these veins is nearly identical between all wild-type wings. The space between veins is 
called the intervein tissue. There are four longitudinal veins, L2-L5. These veins cross the 
length of the entire wing. There are also two transverse veins, the anterior cross vein and 
the posterior cross vein (acv, pcv), which are much shorter and connect the L3 and L4 
veins, and the L4 and L5 veins, respectively. Veins L3, L5, and the distal part of L4 are 
dorsal wing veins and are located on the dorsal side of the wing (28, 29). The rest are 
considered ventral. Two other veins, L1 and L6 exist as well, however they do not extend 
into the wing blade (28). 
 
 
Gal4 
 
 UAS Gene of interest 
Expression of gene of interest 
Tissue-specific promoter in Gal4-expressing flies activates Gal4 expression  
                 Figure 2.  UAS-Gal4 system in Drosophila 
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Figure 3. Drosophila melanogaster wild-type female wing.  
 
10X, mounted dorsally in GMM.  
 
 
 A wild-type Drosophila wing is a quite regular structure. It is decorated with short 
cuticular hairs that generally point distally and are resultant of prehairs, which are 
composed of F-actin and microtubules (30). The cells of the developing wing are 
polarized within the plane of epithelium, and are packed regularly as hexagons. One wing 
prehair is produced at the most distal vertex of each cell (Figure 4) (30). 
 
 
      
 
 
 
 
 
 
Figure 4. Wild-type Drosophila wing cells  
 
Each cell is hexagonally shaped with a single wing prehair produced at the distal vertex 
of the cell (31). 
 
L1 
L2 
L3 
L4 
L5 
pcv 
acv 
L6 
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vii. Balancer Chromosomes 
 There are many advantageous genetic tools available when using Drosophila. One 
quite useful and widely used tool is the balancer chromosome. In the fly, these 
chromosomes have several characteristics that make doing the genetics easier. Firstly, 
and maybe most importantly, these chromosomes contain multiple inversions, which 
suppress homologous recombination. If the balancer chromosomes do recombine, the 
recombination products may contain duplications or may even lack a centromere. 
Because of these mutations, homologous recombination involving balancer chromosomes 
produces progeny that are not viable. The balancer chromosomes are also homozygous 
lethal, so flies receiving two copies of the balancer do not survive. Additionally, they 
have a dominant phenotype, so if a fly carries the balancer chromosome, it can be easily 
identified. 
 There are four chromosomes in Drosophila melanogaster. The first chromosome 
is the X, and is used with balancers called First Multiple (FM). Chromosome 4 is not 
used with balancers, as no balancer for it exists. The third chromosome balancers are 
called Third Multiple (TM) and may contain the dominant marker Stubble (Sb). When a 
fly carries this balancer, the bristles on its head and thorax are shortened. The second 
chromosome balancer that is often used is Curly of Oster (CyO), and its dominant marker 
is Curly (Cy). Flies that carry this balancer have curly wings. 
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CHAPTER 1 – CHMP1 AND REGULATION OF GROWTH 
 
 
Section 1. Introduction 
 
Section 1.1: Overview of Chmp1 
Cell proliferation, growth, and migration are regulated by a myriad of different 
proteins and pathways, the regulation of which is essential to proper cell behavior. One 
small divergence of this tight regulation can cause severe problems in the cell, including 
uncontrolled cell growth, or tumors. Tumor suppressors are a set of genes that govern a 
variety of normal activities in the cell, ranging from cell cycle checkpoint control to 
protein turnover to DNA damage (32). When tumor suppressors are absent or expressed 
at low levels, problems such as over-proliferation can occur. In many types of cancers, 
tumor suppressor genes have low expression levels or are mutated.   
Recent work at the Marshall University School of Medicine has shown that 
Chmp1A regulates proliferation in zebrafish and in mammalian cell culture. Both the 
over-expression and knockdown of Chmp1A in zebrafish embryos causes hyperplasia 
formation, suggesting that Chmp1A is involved in the regulation of growth (33). When 
looking at HEK 293 (Human Embryonic Kidney) cultured cells, Chmp1A over-
expression significantly inhibits growth by arresting cells in S-Phase (13), while Chmp1A 
knockdown promotes growth (33). Additionally, HEK 293 cells with reduced Chmp1A 
activity form tumors when injected into nude mice, while control HEK 293 cells do not 
(33).  
Chmp1A has been linked to pancreatic cancer in humans, as pancreatic tumors 
show a considerable reduction of Chmp1A activity (33). A recent study shows that 
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knockdown of Chmp1A in a pancreatic tumor cell line (PanC-1) promoted growth, while 
over-expression inhibited growth, and was also associated with an increase of p53, an 
extremely important tumor suppressor (22).  These results provide evidence that Chmp1A 
functions in the regulation of growth, since when it is lost growth control is abnormal. 
This suggests that Chmp1 may function as a tumor suppressor, at least in the human 
pancreas (22). 
To date, there are no published Chmp1 (homologue of human Chmp1A) function 
studies in Drosophila. As this is the first study on Chmp1 function, we began at a 
classical starting point by simply looking at Chmp1 knockdown and over-expression. 
Chmp1 was knocked down and over-expressed in the Drosophila wing. Chmp1 
knockdown resulted in oversized wing veins that looked as if they had overgrown. The 
phenotype obtained in the Chmp1 knockdown wings is very similar to phenotypes 
obtained in wings with over-active EGF, suggesting a possible role for Chmp1 in 
regulating EGF activity. When Chmp1 was over-expressed in the Drosophila wing, the 
phenotypes obtained were similar to reduction of Delta (34), a protein involved in Notch 
signaling. This suggests a possible role for Chmp1 in the regulation of Notch signaling as 
well. As altering Chmp1 activity produces phenotypes which are suggestive of Notch and 
EGF regulation, it is appropriate to overview these pathways. 
 
Section 1.2: Epidermal Growth Factor Pathway (Figure 5) 
In humans, EGF signaling plays an important role in the regulation of cell growth, 
migration, differentiation, and proliferation (35). In Drosophila, proper EGF signaling is 
crucial in many developmental processes including oogenesis (36), eye development (37, 
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38), growth of imaginal discs (39), and wing vein development (40, 41). The EGF 
receptor is a transmembrane protein, which functions a receptor tyrosine kinase.  Binding 
of the EGF receptor activates the Ras signaling pathway, which ultimately results in 
altered gene expression (42, 43). The EGF pathway is regulated by a several feedback 
mechanisms. Many different inhibiting and activating molecules regulate the EGF 
receptor pathway, which are often induced by EGF receptor activity (44).  
The three known negative regulators of EGF signaling in Drosophila are Argos 
(Aos), Sprouty (Sty), and Kekkon-1 (Kek-1). Aos is a secreted molecule specific for the 
EGF receptor. It blocks ligand binding and can affect many surrounding cells (44, 45). 
Sty is an intracellular inhibitor, which inhibits Ras signaling, thereby inhibiting EGF 
signaling (46). Kek-1 is a transmembrane protein that interacts directly with the EGF 
receptor to inhibit ligand binding (47, 48).  
There are several different activating ligands of EGF receptor: Spitz, Gurken, 
Vein, and Keren.  Gurken is expressed only in the oocyte and is important for oogenesis 
(49). Vein (Ve) is a secreted factor that binds and activates the EGF receptor (50). Keren 
is a transmembrane protein that must be cleaved in order to become active (51). Lastly, 
Spitz is the major EGF ligand, which, like Keren, is a transmembrane protein that is 
inactive until cleaved (52). The transmembrane protein called Rhomboid (Rho), also 
known as Veinlet (Vn), is not a ligand of the EGF receptor; however it is an important 
activator of EGF in that both Spitz and Keren are present, but do not become active until 
cleaved by Rho (53, 54). 
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Figure 5. Regulators of the Drosophila EGF receptor (EGFR).  
 
The three known inhibitors (red) are Spry, Kek-1 and Aos. The two known activators 
(green) are Ve and Rho (Vn) (107). 
 
 
   
Section 1.3: Notch-Delta Signaling 
Notch-Delta signaling is conserved in animals and has multiple essential activities 
during development such as lateral inhibition, boundary formation and cell fate decisions 
(55). Notch is a single pass transmembrane receptor protein, which was originally 
identified in Drosophila (56). In Drosophila, there is only one Notch protein, and it is 
expressed as a heterodimer
5
 at the membrane (57, 58). It has an ectodomain called the 
Notch Extracellular Domain (NECD), which is involved in binding interactions, a Notch 
Intracellular Domain (NICD) critical for protein-protein interactions and transcriptional 
activation (59, 60, 61). Notch responds to two ligands, Delta and Serrate, which are also 
membrane-bound proteins (62, 63, 64). Ligand binding of the NECD leads to cleavage of 
                                               
5
 The Notch protein forms a homodimer at the membrane. However, for Notch to be 
active, one of the units is cleaved, leaving a heterodimer at the membrane (58). 
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the NICD, which translocates to the nucleus where it interacts with Suppressor of 
Hairless [Su(H)], a DNA-binding protein, and regulates the transcription of its target 
genes (65, 66). As both the ligands and receptors in Notch-Delta signaling are 
transmembrane proteins, signaling is short range. 
As wings go, Notch and EGF signaling work together to promote correct wing 
vein formation (Figure 6). Delta is expressed in the center of wing vein territory while 
Notch is expressed in cells bordering the veins (34). Delta expression activates Notch, 
which activates Su(H) (65). Su(H) then activates expression of a gene called Enhancer of 
split [E(spl)mβ] (67). E(spl)mβ then goes on to repress rho transcription (68), confining 
rho expression to the vein, where it activates EGF signaling (40). 
 
 
Figure 6. Notch and EGF signaling regulate vein size in the Drosophila wing. 
 
The blue areas represent the borders of intervein, while the orange represents vein tissue. 
Expression of Rhomboid activates the Der receptor (EGF receptor), which activates 
expression of the Notch ligand, Delta. Delta then activates Notch in the adjacent cell, 
which causes E(spl)mβ to repress Rhomboid expression, restricting Rhomboid, and thus 
EGF signaling, to the vein (28). 
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Section 2. Objective and Hypothesis 
 Section 2.1: Objective 
 The objective of this study was to characterize the function of Chmp1 in 
Drosophila by observing the effects of knockdown and over-expression. Chmp1 
knockdown was achieved using RNAi, and over-expression was achieved by creating a 
transgenic fly line. 
 
 Section 2.2: Hypothesis 
 We hypothesize that Chmp1 in Drosophila will function in the same 
developmental processes as Chmp1A in vertebrates.  
 
 
Section 3. Materials and Methods 
Section 3.1: Gels 
 All gels were 0.8% agarose gels containing ethidium bromide. In a 50mL 
Erlenmeyer flask, 0.4g of agar was added to 50mL of 1X TBE (Tris-Borate-EDTA) 
buffer from a 10X stock solution. The mixture was heated in a microwave for about 35 
seconds, until the agar had dissolved. One uL of ethidium bromide was added to the 
mixture, and it was swirled until well mixed. The gel was poured and allowed to cool. 
All gels were run at 120 volts for approximately 90 minutes alongside 1KB DNA ladder. 
They were run in 1X TBE buffer, and analyzed on a GelDoc (Biorad, Hercules, CA, 
USA). 
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Section 3.2: Transformation of E. coli cells 
The competent cells were thawed on ice, and 50uL was added to a 1.5mL 
microcentrifuge tube. 0.85uL of -mercaptoethnol was added to the cells, and then they 
were incubated on ice for 10 minutes, swirling every 2 minutes. 10uL of DNA was added 
to the cells, and they were incubated on ice for 30 minutes. In the meantime, 100uL of 
LB Broth was heated in a 42
o
C water bath. At the end of the incubation period, the cell 
tube was heat pulsed in a 42
o
C water bath for 45 seconds, and then placed on ice for 2 
minutes. The cells were then added to the broth tube and incubated at 37
o
C for 30 
minutes. The transformed cells were plated (~75uL/plate) onto LB agar plate containing 
chloramphenicol (final concentration: 2uL/mL) or ampicillin (stock concentration: 
50ug/mL, final concentration: 1uL/mL), depending on the vector’s resistance, and grown 
overnight at 37
o
C. The next day, individual colonies were selected
6
 and cultured in 
200mL of LB broth containing their specific antibiotic, and shaken overnight at 150rpm 
at 37
o
C. The DNA was then purified using a Qiagen HiSpeed Plasmid Midi Kit 
(Valencia, CA, USA), following the manufacturer’s procedures. The DNA was separated 
on a gel and analyzed. 
 
Section 3.3: Plasmid preparations 
 All large plasmid preparations were made using 200mL of LB broth and either 
2ul/mL of chloramphenicol or 1uL/mL of ampicillin, depending on the vector’s 
                                               
6
 The pBluescript vector allowed for blue/white color selection. When using this vector, 
the plates were covered with a mixture of IPTG (72ug/mL) and X-Gal (40ug/mL) before 
plating. The white colonies that grew represented transformed cells, while blue colonies 
represented non-transformed cells. 
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resistance. They were shaken overnight at 37
o
C and purified using the Qiagen HiSpeed 
Plasmid Midi Kit (Valencia, CA, USA).  
 All small plasmid preparations were made using 3mL of LB broth and either 
ampicillin or chloramphenicol. They were shaken overnight at 37
o
C and purified using 
the Qiagen QIAprep Spin Miniprep Kit (Valencia, CA, USA). 
 
Section 3.4: Digests 
 All digests were 100uL solutions in a 1.5mL microentrifuge tube. Digests were 
always performed in sets of two so they could be combined and used in a 
phenolchloroform extraction. The digests consisted of 10uL of DNA (~5ug) solution, 
10uL of buffer, 70uL of water and 10uL of enzymes (Table 3). The digests were 
incubated at 37
o
C for 1 hour, then run on a gel and analyzed.  
 
Section 3.5: Phenolchloroform extraction 
In a 1.5mL microcentrifuge tube, 200uL of phenol chloroform was added to 
200uL
7
 of DNA solution and vortexed for 10 seconds, and then centrifuged for 4 minutes 
at maximum speed. The top layer (~200uL) was removed and transferred into a new 
microcentrifuge tube. Then 20uL of 3M pH5.2 sodium acetate was added and mixed by 
vortexing. 400uL of isopropanol
8
 was added and mixed by vortexing. The sample was 
incubated for 30 minutes on ice, and then centrifuged at maximum speed for 8 minutes to 
pellet the DNA. The supernatant was discarded and the pellet was washed with 70% 
                                               
7
 For digests and PCR products, combine two vials (100uL each) to make a 200uL 
sample of DNA solution.   
8
 When purifying cDNA, 100% ice cold ethanol was used.  
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ethanol and microcentrifuged again. The supernatant was again discarded, and the pellet 
was air dried overnight. The next day, 20uL of buffer EB from Qiagen’s QIAprep Spin 
Miniprep Kit (Valencia, CA, USA) was added to resuspend the pelleted DNA. The DNA 
solution was then run on a gel and analyzed. 
 
Section 3.6: Chmp1 insertion into pUAST and pUASHM 
Chmp1 cDNA was digested out of the pBluescript vector in 8 - 100uL digests of 
each construct containing 40uL (~20ug) of DNA solution, 10uL of their respective 
enzymes (Table 3), and 10uL of their respective buffer and 40uL of water. Then 4 – 
200uL phenol chloroform extractions of each construct. The samples of each construct 
were loaded on gel. Eight wells were used, and each well contained 10uL of sample and 
2uL of 10X loading dye, and were run alongside a 1kb DNA ladder for about 90 minutes 
in 1X TBE buffer 
 
Section 3.7: Ligation 
 All ligations were 10uL of solution prepared in a 1.5mL microcentrifuge tube. 
They consisted of 1uL of T4 DNA ligase, 1uL ligase buffer, 3uL of vector (~1ug/uL), 
4uL of cDNA (~1ug/uL) and 1uL of water. They were incubated at 4
o
C overnight. 
 
Section 3.8: Fly food preparation 
 In a large pot over a burner, 1000mL of distilled water was mixed with 18 grams 
of agar. The mixture was heated and stirred. In the meantime, 500mL of water was added 
to 30 grams of Brewer’s yeast, along with 120 grams of cornmeal in a 1000mL beaker. 
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Once the water/agar mixture began to boil, 225mL of molasses was added while stirring, 
followed by the cornmeal/yeast mixture. While stirring frequently, the mixture was 
brought to a boil. It was cooled with lid on for 10 minutes, and cooled with the lid off, 
stirring occasionally, for 30 minutes (vials) to an hour (bottles). After the cooling period, 
13.2mL of propionic acid and 42.75mL of hydrobenzoic acid were added. The mixture 
was stirred and poured into either bottles or vials. The bottles/vials were stored overnight 
at 18
o
C to completely cool and plugged the next day with cotton. 
 
Table 1. Primers used for PCR 
Restriction enzyme sites in bold. GGATCC: BamH1, CATATG: Nde1, CTCGAG: Xho1, 
GAATCC: EcoR1  
 
Name Sequence 
pUASHM forward GGGCCCGGATCCACGTCGCATATGTCTACGAGTT 
CCATGG 
pUASHM reverse TACCACCTCGAGTTATTCAGCCTGGCGGAGACG 
pUAST forward ACGTCGGAATCCATGTCTACGGAGTTCCATGG 
pUAST reverse TACCACCTCGAGTTATTCAGCCTGGCGGAGACG 
 
 
Table 2. Primers used for sequencing 
 
Name Sequence 
pUAST, pUASHM forward TGCAACTACTGAAATCTGC 
pUAST, UASHM reverse CCAATTATGTCACACCACAG 
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Table 3. Enzymes used.  
The enzymes next to the number one were used with the first construct (Chmp1 insertion 
into pUASHM) and enzymes next to the number two were used with the second construct 
(Chmp1 insertion into pUAST). 
 
Vector Enzymes 
Digest of Chmp1 PCR product  1. BamH1 and Xho1 
2. EcoR1 and Xho1 
Digest of pBluescript 1. BamH1 and Xho1 
2. EcoR1 and Xho1 
Digesting Chmp1 out of pBluescript 1. Nde1 and Xho1 
2. EcoR1 and Xho1 
Digest of pUASHM       1.   Nde1 and Xho1 
Digest of pUAST       2.   EcoR1 and Xho1 
 
 
Table 4. Genotypes of flies used 
 
Name Genotype 
Oregon R (wild-type) Oregon R-C 
Chmp1IR (VDRC) w
1118
; P{GD11219}v21788/CyO 
Chmp1IR (TriP) y
1
 v
1
; P{TRiP.HM05117}attP2 
MS1096-Gal4 w
1118
 P{w
+mW.hs
=GawB}Bx
MS1096
 
argos
7
 argos
Delta7
/TM3, Sb
1
 
argos
w11
 w
8
; P{w
+mW.hs
=lwB}argos
W11
/TM3, Sb
1
 
UAS-argos on 1 &2 
y
1
,w
*
P{w
+mC
=UASargos.M}301021;P{w
+mC
=
UAS argos.M}30-85-1 
sty
5
 w*; sty
Delta5
/TM3, Sb
1
 P{w
+mC
=35UZ}2 
argos
r/t
 argos
r/t
 
kek-1 y
1
 w
p67c23
; P{y
+t7.7
 w
+mC
=wHy}kek1
DG23812
 
ve vn rho
ve-1
, vn
1 
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Section 4: Results 
 To date, there are no published studies on Chmp1 function in Drosophila. 
Classically, protein and gene studies begin with over-expression and knockdown. 
Because no one has studied Chmp1, no classical mutant exists. So in order to obtain 
Chmp1 knockdown, a transgenic RNAi fly line was obtained from the Vienna Drosophila 
Resource Center (69). This fly line will allow for control of Chmp1 knockdown, because 
the Chmp1 RNAi transgene is downstream of a Gal-4 responsive UAS promoter. In order 
to look at Chmp1 over-expression, transgenic fly lines had to be created. Two expression 
vectors were used: pUAST and pUASHM, both of which mediate random insertion of the 
transgene into the Drosophila genome. Each of these vectors allowed for Chmp1 
transgene insertion downstream of a Gal4-responsive UAS promoter, which permits fine 
control of Chmp1 over-expression once in the fly.  The pUASHM vector will tag the 
Chmp1 protein with an N-terminal HisMyc (HM) tag that will allow for visualization and 
localization studies in the fly.  
 
Section 4.1: Chmp1 knockdown 
Chmp1 function has not been studied in the Drosophila system. A classical 
Drosophila Chmp1 mutant does not exist, so to study Chmp1 knockdown, RNAi was 
used. A Chmp1 RNAi line was obtained from Vienna Drosophila RNAi Collection 
(VDRC) (69). The Chmp1 RNAi (Chmp1IR) fly line obtained expresses Chmp1 hairpin 
loop RNA (hpRNA), which is complementary to Chmp1 mRNA. The hpRNA is 
expressed under a Gal4 responsive UAS promoter, which allows for very fine control 
over Chmp1 knockdown. Expression of Chmp1 hpRNA initiates the RNAi pathway and 
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mediates the destruction of Chmp1 mRNA, knocking down Chmp1 expression (Figure 7). 
The Chmp1 hpRNA is located on the second chromosome of the fly, and is balanced with 
CyO. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. Mechanism of Chmp1 RNAi in flies.  
 
The hpRNA expressed is double stranded RNA, which is recognized by the cell. An 
enzyme called DICER is recruited to the site and cleaves the hpRNA into 20-22 
nucleotide pieces called small interfering RNAs (siRNA). Then a complex called RNA-
Induced Silencing Complex (RISC) unwinds the double stranded siRNAs. When this 
complex comes into contact with Chmp1 mRNA, the siRNA binds, and RISC cleaves the 
mRNA. The mRNA is then destroyed and recycled in the cell. 
 
 
Section 4.2 (A-E): Generation of Transgenic Flies (Figures 18 and 19) 
 As Chmp1 has not been studied in Drosophila, there was no available fly line that 
would allow for Chmp1 over-expression. Thus, transgenic UAS-Chmp1 fly lines were 
Cleavage of Chmp1 mRNA 
     Chmp1 mRNA destruction 
Unwinding by RISC 
Cleavage of hpRNA 
        by DICER 
Hairpin RNAs 
(complementary to Chmp1 
mRNA) 
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created. This was accomplished by inserting the Chmp1 coding sequence into a vector 
downstream of a UAS promoter. The vectors that contain the UAS promoter and allow 
for Chmp1 insertion are called pUAST and pUASHM. pUASHM adds a HM tag to the 
Chmp1 protein.  
 
Section 4.2 A: cDNA preparation 
Four different vectors were used: GH26351 (pOT2 vector (Figure 20)) containing 
Chmp1 cDNA,) has chloramphenicol resistance, pUAST (Figure 21), pUASHM (Figure 
22) and pBluescript (Figure 23) all have ampicillin resistance. The GH26351 plasmid 
was received from Drosophila Genomics Resource Center (DGRC). Preparations of the 
plasmids were made using XL-1 Blue Competent Cells (Stratagene, La Jolla, CA, USA), 
which were separately transformed by each vector. To check that the vectors were 
correct, they were digested and analyzed on a gel.  
To prepare the vectors (pBluescript, pUAST, pUASHM) for Chmp1 insertion, 
they were digested with the appropriate enzymes (Table 3). The vectors were then 
purified and concentrated using a phenolchloroform extraction. During the 
phenolchloroform extraction, isopropanol was used, removing the linker DNA that was 
digested out of the vector to prevent re-insertion. The DNA was then run and analyzed on 
a gel. At this point, the vectors were ready for Chmp1 insertion. 
Now that the vectors were ready for Chmp1 insertion, a Chmp1 cDNA needed to 
be prepared from GH26351. The Chmp1 cDNA was amplified from the vector using the 
PCR Extender System Kit (5 Prime Inc, Maryland, USA) and a Biometra Tgradient 
Thermoblock (Biometra Biomedizinische Analytik GmbH, Rudolf-Wissell, Goettingen, 
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Germany). Two sets of primers (Invitrogen, Carlsbad, CA, USA) were used to amplify 
Chmp1 from the pOT2 vector (Table 1). The set of primers for the first construct were 
pUASHM forward, which added restrictions cut sites for BamH1 and an Nde1, and 
pUASHM reverse, which added the restriction cut site for Xho1, to allow for insertion 
into the pBluescript and the pUASHM vectors. The set of primers for the second 
construct were: pUAST forward, which added a restriction cut site for EcoR1, and 
pUAST reverse, which added the restriction cut site for Xho1, to allow for insertion into 
the pBluescript and the pUAST vectors. The cycling parameter for amplifying PCR 
products was 30 cycles of 94
o
C for 30 seconds, 55
o
 for 30 seconds and 72
o
C for 2 
minutes.
 
Eight individual but identical PCR vials were run. DNA from PCR was run and 
analyzed on a gel. 
 
Section 4.2 B: Preparing Chmp1 for insertion into pBluescript 
As the pUAST and pUASHM vectors are quite large and less ready to be taken up 
during a transformation, the PCR-amplified Chmp1 cDNA was first inserted into the 
much smaller pBluescript vector.  The cDNA from PCR was purified and concentrated 
by a phenol-chloroform extraction. The concentrated DNA was then digested with 
enzymes respective to which vector it would be inserted. The DNA of the first PCR 
product
9
 was digested with BamH1 and Xho1, while the DNA of the second PCR 
product
10
 was digested with EcoR1 and Xho1. The DNA was then purified and 
concentrated using a phenol-chloroform extraction. Chmp1 was now ready for insertion 
into pBluescript. 
                                               
9
 Product of PCR performed with pUASHM primers 
10
 Product of PCR performed with pUAST primers 
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Section 4.2 C: Chmp1 in pBluescript 
The precipitated pBluescript vector and each Chmp1 preparation were combined 
in a ligation. XL-1 Blue Competent Cells were transformed. The pBluescript vector 
allowed for blue/white color selection. When using this vector, the plates were covered 
with a mixture of IPTG (72ug/mL) and X-Gal (40ug/mL) before plating. The white 
colonies that grow represent transformed cells, while blue colonies represent non-
transformed cells. So the next day, individual white colonies were selected and made into 
small preparations and grown overnight. The plasmid was then purified using the Qiagen 
QIAprep Spin Miniprep Kit (Valencia, CA, USA). To check that the transformation was 
successful and that the plasmids were correct, the DNA was digested with enzymes that 
should release the insert, and run on a gel and analyzed. Large preparations of DNA were 
made with the samples that appeared to have the correct vector and insert size, and then 
sequenced, to ensure that the Chmp1 sequence was correct, by the Genomics Core 
Facility of Marshall University’s Joan C. Edwards School of Medicine, using the M13 
forward and reverse primers. 
 
Section 4.2 D: Preparing Chmp1 for insertion into pUAST and pUASHM 
When the correct Chmp1 sequence was obtained, it was then removed from the 
pBluescript vector, and inserted into the pUAST and pUASHM vectors. Very high cDNA 
concentrations were required for this section of the protocol because the last step was a 
gel extraction, which was not extremely efficient in recovering DNA. The Chmp1cDNA 
was digested out of the pBluescript vector. A large amount of plasmid DNA was digested 
in order to maximize the amount of digested Chmp1 cDNA. To concentrate the cDNA, 
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the digests were precipitated in a phenol-chloroform extraction. The samples of each 
construct were loaded and run on gel. The gels were then analyzed under UV light and 
the inserts were cut out and collected using the QIAquick Gel Extraction Kit (Qiagen, 
Valencia, CA, USA). The DNA solution obtained from the gel extraction was run on a 
gel to ensure that the procedure was successful. When a high concentration of Chmp1 
was obtained, it was then ready to be inserted into the pUAST and pUASHM vectors. 
 
Section 4.2 E: Chmp1 in pUAST and pUASHM 
Now that Chmp1 was ready for insertion into pUAST and pUASHM, the cDNA 
could now be ligated into the vectors. Two ligations were performed, one for each 
construct. XL1-Blue Ultra Competent Cells (Stratagene, La Jolla, CA, USA) were 
transformed separately by each ligation. The next day, individual colonies were selected 
made into small preparations, and grown overnight.  The plasmid was then purified using 
Qiagen’s QIAprep Spin Miniprep Kit (Valencia, CA, USA), and digested to check for the 
correct vector and insert size. The samples that appeared to be correct were made into 
larger preparations and purified with the HiSpeed Plasmid Midi Kit (Qiagen, Valencia, 
CA, USA). The plasmids were then sequenced by the Marshall University Genomics Core 
Facility with custom primers (Invitrogen, Carlsbad, CA, USA). The same primers were 
used for both pUAST and pUASHM sequencing (Table 2).  
When the correct sequence was obtained, the samples were then prepared for 
insertion into the Drosophila genome. A commercial generator of transgenic flies called 
BestGene Inc. (Chino Hills, CA, USA) was used. They required at least 50uL of DNA 
with a concentration of 1ug/uL. The concentrations of pUAST and pUASHM vectors 
26 
 
containing the correct Chmp1 sequence were measured using a ND-1000 
spectrophotometer (NanoDrop Technologies, Wilmington, DE, USA). A concentration of 
1ug/uL was needed, but was not obtained. The Qiagen HiSpeed Plasmid Midi Kit 
produces about 1mL of purified plasmid in solution; so, to obtain a higher concentration, 
400uL of each plasmid solution was concentrated by a phenolchloroform extraction and 
resuspended in 50uL of water. The concentrations were measured again using a ND-1000 
spectrophotometer, and each had reached a concentration of 1ug/uL or higher. The 
plasmids were then sent to BestGene Inc. (California, USA).  
BestGene Inc. provided the service of integrating the Chmp1 transgene into the 
Drosophila genome. Both the pUAST and pUASHM vectors have P elements, which are 
transposons that are often used in Drosophila to create genetically modified flies. These P 
elements function to insert the Chmp1 transgene and a white gene together into the 
genome of the fly (Figure 8). This process is random, and therefore gives rise to the 
possibility of insertion within a gene, or multiple insertions. The white gene, which gives 
the eye of the fly a red color, serves as a marker so that only flies with the white
+
 
phenotype have the Chmp1 transgene. 
The Chmp1 constructs that were created, along with a helper plasmid, were 
injected near/into the germ cells of white
-
 (white eye) embryos. The helper plasmid 
encodes a transposase, which is required to insert the transgene into the genome. Some of 
the germ cells take up the plasmids, and the Chmp1 transgene and the white gene get 
inserted into the genome of those cells. When the injected white
-
 embryo develops into an 
adult fly, it can be crossed to another white
- 
fly. The successful BestGene lines had the 
Chmp1 transgene, which was evident by its white
+
 phenotype.  
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Figure 8. P-elements and transgenes. 
 
Both the pUAST and the pUASHM use P elements to insert the Chmp1 transgene into the 
genome of the fly. The P elements also insert the white gene, which functions as a 
indicator that a fly has the Chmp1 transgene. 
 
Twenty separate and successful fly lines (ten for each vector preparation) were 
returned from BestGene Inc. In order for these fly lines to be very useful, it will be 
necessary to determine the chromosome of Chmp1 insertion. The lines will also have to 
be balanced to ensure that the stock remains stable. 
 
Section 4.3 (A & B): Over-expression and knockdown of Chmp1 in the wing 
When beginning a study on protein function, the usual place to begin is to observe the 
results of loss of function, or losing protein activity, as well as gain of function, or over-
expression of that protein. The results and phenotypes of these first two studies can give 
insight to the protein’s function. Drosophila is a very well studied model organism. So, if 
mis-expression of a protein interrupts a signaling pathway, the phenotypes observed may 
give a clear indication as to which pathways that protein is involved.  
 
Section 4.4 A: Knockdown of Chmp1 in the wing 
 Now the tools were available to both over-express and knock down Chmp1 in the 
fly. Achieving Chmp1 knockdown was very simple; using the RNAi fly line, it only 
required a single generation cross.  In the RNAi line, the Chmp1IR transgene is under the 
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control of a UAS promoter, meaning Chmp1 hpRNA is only expressed in the presence of 
the Gal4 protein. A single generation cross between Chmp1IR virgin females and males 
that express Gal4 in the wing will result in offspring with Chmp1 knockdown in the wing 
(Figure 9).    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. Drosophila single generation cross to achieve Chmp1 knockdown 
 
 
The Gal4 line that was used is called MS1096-Gal4. MS1096-Gal4 only drives 
Gal4 expression in certain parts of the fly, most strongly on the dorsal side of the 
developing wing. Three separate crosses were set up, each with ten virgin Chmp1IR/Cy 
females to ten MS1096-Gal4/Y; Cy/Sco males. One cross was kept at 25
o
C, one at 28
o
C, 
and one at 30
o
C. The parent generation was moved to a new vial with fresh fly food every 
two to three days. When the first generation of these crosses was fully developed, the 
Fly expressing  
Gal4 in wing  Chmp1IR fly 
Fly with Chmp1 knockdown 
 in wing 
x 
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right wing of MS1096-Gal4/X; Chmp1RNAi/Sco female flies was dissected off, and 
mounted dorsally onto a microscope slide in GMM (70). It should be mentioned that for 
all of the crosses completed in these studies, the first generation was quite large (>100 
flies). For every cross that was performed, at least 50 flies were analyzed and at least 10 
wings were mounted. The results presented for each cross were consistent and 
representative of the relative first generations. 
When Chmp1 was knocked down in the wing of the flies, the result was 
overgrowth of dorsal wing veins L3 and L5 (Figure 10B). Overgrowth of wing veins is a 
phenotype that is often associated with over-active EGF signaling. The results from this 
initial Chmp1 knockdown suggest that Chmp1 may be involved in regulation of growth 
in Drosophila, as it seems to be so in zebrafish and mammalian cell culture. More 
specifically, it seems that Chmp1 may be involved in regulating EGF signaling. As 
knockdown of Chmp1 results in phenotypes similar to over-active EGF, Chmp1 may 
negatively regulate the EGF pathway.  
In order to investigate this possibility further, Chmp1 was knocked down in the 
wing, while at the same time reducing activity of the positive and negative regulators of 
the EGF pathway. Some only slightly more complicated crosses were performed to check 
for Chmp1 involvement in EGF signaling. MS1096-Gal4/X; Cy/Sco virgin females were 
again crossed to Chmp1IR males. From that cross, first generation males that were 
MS1096-Gal4/Y; Chmp1IR/Sco were collected and used for six separate crosses. They 
were crossed to vevn, kek-1, aos
Δ7
, aos
w11
 and sty
Δ5
 virgin females
11
. All of these 
                                               
11
 In Drosophila, fly lines are often named for their mutation. So an Argos fly is deficient 
in Argos protein, or an Argos mutant. All of the EGF mutants used in this study were 
heterozygous mutants, with the exception of vevn. 
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mutations are heterozygous, and therefore only reduce the activity of the protein/gene for 
which they are specific. Three vials of each cross were prepared with one kept at 25
o
C, 
one at 28
o
C, and one at 30
o
C. When the flies from these crosses were fully developed, the 
right wing of MS1096-Gal4; Chmp1IR; heterozygous EGF mutant female flies was 
dissected off and mounted dorsally on a microscope slide in GMM.  
EGF signaling is very important for the formation of wing veins. When EGF is 
over-active, the result is over-sized wing veins. On the contrary, when EGF is reduced, 
wing veins are reduced in size or even missing. Wings lacking both ve and vn (rho) 
(activators of EGF) have no veins (71), because when the activators of EGF are missing, 
the only regulators of EGF present are repressors, and thus EGF signaling is significantly 
repressed. However, Drosophila wings heterozygous for vein and rho (ve) alleles are wild 
type, suggesting that reduced activity of vein and rho is sufficient to achieve proper EGF 
signaling. Chmp1 knockdown in the wing results in overgrowth wing veins, suggesting 
that EGF becomes over-active in the absence of Chmp1 (Figure 10).  
So what happens when Chmp1 is knocked down at the same time as reducing Ve 
and Vn? When Chmp1 was knocked down in the wing in heterozygous for alleles of the 
activators of the EGF pathway, rho (ve) and vein, the result was a normal sized wing vein 
(Figure 10C). This is very interesting, as it seems that the Chmp1IR phenotype requires 
EGF activators because without them, the Chmp1IR phenotype is extinguished and the 
wing appears to be wild-type.  This suggests that Chmp1IR phenotype is dependent upon 
the EGF pathway and that Chmp1 may be regulating EGF signaling.  
Chmp1 was also knocked down in the wing in combination with reduced activity 
(heterozygous mutants) of each of the negative regulators of EGF (kek-1, sty
Δ5
, and aos
Δ7
) 
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separately (Figure 10 D-F). The result was wing veins that were much larger than those 
acquired by sole Chmp1 knockdown. Knocking down Chmp1 and reducing just one of 
the EGF negative regulators greatly enhances the Chmp1IR phenotype. However, wings 
that were heterozygous for kek-1, sty
Δ7
, or aos
Δ7
 separately appeared to be wild type. This 
result also suggests that the Chmp1IR phenotype is dependent on the EGF pathway and 
offers more evidence that Chmp1 is specifically important for proper EGF signaling, and 
thus wing vein development. 
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Figure 10. Chmp1 knockdown in the wing. 
 
All wings were developed at 28
o
C. A. Oregon R : a wild-type wing with normally sized 
wing veins. B. MS1096-Gal4; UAS-Chmp1IR: Chmp1 knockdown in the wing results in 
wider wing veins. C. MS1096-Gal4; UAS-Chmp1IR; rho
ve-1
, vn
1
/+: Chmp1 knockdown, 
along with reduced activity of EGF positive regulators rho and vein results in wild-type 
sized wing veins. D. MS1096-Gal4; UAS-Chmp1IR; argos
7
/+: Knockdown of Chmp1 
along with reduced activity aos, a negative regulator of EGF, results in veins much wider 
than those observed with sole Chmp1 knockdown. E. MS1096-Gal4; UAS-Chmp1IR; 
sty
5
/+: Knockdown of Chmp1 along with reduced activity of sty, a negative regulator of 
EGF, results in much wider veins. F. MS1096-Gal4; UAS-Chmp1IR; kek1/+: 
Knockdown of Chmp1 along with reduced activity of kek-1, a negative regulator of EGF, 
also results in much wider veins. 
 
  
 RNAi fly lines express hpRNA, specific to a gene of interest, under the control of 
a Gal4 responsive UAS promoter. The creation of an RNAi line is not a foolproof 
process, and there are several problems of which to be aware. For example, when the 
A 
B 
C 
D 
E 
F 
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transgene coding hpRNA is inserted into the genome of the fly, the insertion is 
completely random. This could be problematic, as insertion within or near a gene could 
affect or even disrupt that gene’s expression. Additionally, when the hpRNA is 
expressed, it is supposed to cause destruction of the mRNA for which it is specific. 
However, there is the possibility that the hpRNA does not target the mRNA well, or that 
it could target a different mRNA in addition to Chmp1 mRNA. Therefore, it is important 
to assess whether the phenotypes we observe are actually due to Chmp1 knockdown, 
rather than a result of the transgene’s position within the genome of the fly, or a 
malfunction of the hpRNA. There is another Chmp1 RNAi fly line available from 
Harvard Medical School’s Transgenic RNAi Project (TRiP) (72). This Chmp1 RNAi line 
is different from the VDRC line in that the hpRNA is on a different chromosome, and it 
targets a different portion of the Chmp1 mRNA (Flybase). Therefore, observing similar 
phenotypes from both the TRiP Chmp1IR line and the VDRC Chmp1IR fly line would be 
good evidence that the phenotypes previously obtained were in fact due to Chmp1 
knockdown. 
 In order to test this, TRiP Chmp1IR female virgin flies were crossed to MS1096-
Gal4 males. The adult flies were moved to a vial of fresh food every 2-3 days and the 
developing first generation was incubated at 25
o
C, 28
o
C and 30
o
C. The right wing of the 
first generation adult female flies were dissected off and mounted dorsally on a 
microscope slide in GMM. Chmp1 was knocked down using the TRiP flies resulted in 
wing vein overgrowth, a phenotype very similar to that obtained from Chmp1 knockdown 
using the VDRC fly line (Figure 11). This offers evidence that the Chmp1 knockdown 
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and interaction phenotypes obtained previously were in fact due to Chmp1 knockdown, 
rather than off-target effects. 
 
 
 
 
 
 
 
 
 
 
Figure 11. TRiP Chmp1 knockdown in the wing at 28
o
C 
 
 
Section 4.3 B: Over-expression of Chmp1 in the wing 
When beginning a study on protein/gene function, the classical place to begin is 
knockdown and over-expression. We were able to look at knockdown rather easily using 
an RNAi line. As we have only recently acquired the resources available to study over-
expression, Chmp1 over-expression has only been very briefly investigated. 
 The transgenic fly lines that were created are designed to work using the UAS-
Gal4 system. Chmp1, located downstream of a Gal-4 responsive UAS promoter, was 
inserted into the genome of the fly. Therefore, a simple cross of a UAS-Chmp1 fly line to 
a Gal4 driver fly line should be sufficient to achieve Chmp1 over-expression. As 
mentioned before, twenty different fly lines were created. Ten of the fly lines express a 
Chmp1 protein tagged with HM, and the other ten are untagged. It is important to know 
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the phenotypes of most, if not all lines for several different reasons. Firstly, the Chmp1 
cDNA was inserted randomly into the genome. This means it could have been inserted 
within or near genes whose mis-expression could lead to false Chmp1 phenotypes. Also, 
as one of the Chmp1 lines is tagged, it is possible that a tag could affect Chmp1 protein 
activity, thereby resulting in a false phenotype. If Chmp1 is over-expressed in many of 
the fly lines and similar phenotypes are obtained from all of them, the phenotype 
observed is most likely a result of Chmp1 over-expression. It is likely that the phenotypes 
will be slightly different, depending on the location of the Chmp1 transgene insertion. If 
Chmp1 was inserted into a highly expressed part of the genome, stronger phenotypes 
should be obtained. On the other hand, if Chmp1 was inserted into a weakly expressed 
portion of the genome, expression will be hindered and weak phenotypes will result.  
 UAS-Chmp1 male flies were crossed to MS1096-Gal4 virgin females. The parent 
generation was transferred to a new vial of fly food every 2-3 days. The developing first 
generation flies were incubated at 25
o
C, 28
o
C and 30
o
C. When the flies were fully 
developed, the right wings of males and females were dissected off and mounted dorsally 
onto a microscope slide in GMM. 
 To date, nineteen of the twenty lines have been investigated, and all of the 
phenotypes obtained have been very similar. The last line did not survive and therefore 
could not be investigated. Chmp1 over-expression in the wing of the fly results in:  1.) 
occasional loss of the anterior cross vein (acv) and/or posterior cross vein (pcv); and, 2.) 
phenotypes indicative of problematic Notch-Delta signaling, specifically, reduction of 
Delta (M-89). The phenotypes obtained from both tagged (Figure 14) and untagged 
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(Figure 13) UAS-Chmp1 lines are similar, suggesting that the phenotype is real, and that 
the activity of the epitope-tagged Chmp1 protein is not altered by the HM tag. 
The vein phenotypes observed are quite similar to phenotypes observed when the 
fly wing has decreased activity for Notch signaling ligand, Delta (Figure 12). Since 
altering Chmp1 activity produces a phenotype related to faulty Notch signaling, Chmp1 
may be involved in regulating the Notch pathway. These results are very recent, and 
further investigation into the involvement of Chmp1 with the Notch pathway is needed. 
 
 
 
 
 
 
 
 
 
 
 
Figure 12.  Loss of Delta in Drosophila wing 
 
Adult wing phenotype of Dl
PlacZ
/Dl
RF
 developed at 18
o
C causes reduction in Delta 
activity. Chmp1 over-expression phenotypes resemble reduction of Delta phenotypes 
(34). 
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Figure 13. Over-expression of Chmp1 in the wing. 
 
A. MS1096-Gal4; UAS-Chmp1 5491-2-2M male wing developed at 25
o
C. B. MS1096-
Gal4; UAS-Chmp1 5491-2-2M male wing developed at 28
o
C. C. MS1096-Gal4; UAS-
Chmp1 5491-2-2M male wing developed at 30
o
C.  D. MS1096-Gal4; UAS-Chmp1 5491-
2-4M male wing developed at 25
o
C. E. MS1096-Gal4; UAS-Chmp1 5491-2-4M male 
wing developed at 28
o
C.  F. MS1096-Gal4; UAS-Chmp1 5491-2-4M male wing 
developed at 30
o
C. 
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Figure 14. Over-expression of tagged Chmp1 in the wing. 
 
A. MS1096-Gal4; UAS-Chmp1 5491-1-6M male wing developed at 25
o
C. B. MS1096-
Gal4; UAS-Chmp1 5491-1-6M male wing developed at 28
o
C. C. MS1096-Gal4; UAS-
Chmp1 5491-1-6M male wing developed at 30
o
C.  D. MS1096-Gal4; UAS-Chmp1 5491-
1-3M male wing developed at 25
o
C. E. MS1096-Gal4; UAS-Chmp1 5491-1-3M male 
wing developed at 28
o
C.  F. MS1096-Gal4; UAS-Chmp1 5491-1-3M male wing 
developed at 30
o
C. 
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Section 5: Discussion 
To date, studies with Chmp1 and its homologues show that mis-expression of 
Chmp1 causes overgrowth (22, 33).  Chmp1 knockdown in the Drosophila wing results 
in oversized wing veins. This result suggests that Chmp1 is involved in regulation of 
growth in Drosophila. This is consistent with previous research and suggests that 
Drosophila is a good model for studying Chmp1 function. The establishment of wing 
veins in the Drosophila wing is dependent upon EGF and Notch-Delta signaling. Since 
mis-expression of Chmp1 results in vein phenotypes, Chmp1 may be regulating these 
pathways.  
As these pathways are quite dependent upon each other in the formation of wing 
veins, it is possible that Chmp1 is involved in the regulation of only one of the pathways. 
Chmp1 knockdown phenotypes suggest that Chmp1 is regulating EGF signaling, while 
over-expression phenotypes suggest that it is regulating Notch-Delta signaling. It is not 
clear yet exactly how Chmp1 is acting on these two pathways. One possibility is a simple 
matter of ESCRT function. It is probable that Chmp1 over-expression and knockdown 
would have an effect on ESCRT, as it is a functioning member of the protein complex. 
Significantly, both the EGF and Notch pathways are reported in the literature to be 
regulated by ESCRT machinery. Studies with EGF signaling and ESCRT have shown 
that deletion of ESCRT-III component Vps24 (also known as Chmp3) results in 
persistent EGF signaling (73). This information is consistent with our results that a defect 
in ESCRT-III component Chmp1 results in over-active EGF signaling as well. In the 
Notch-Delta pathway, Notch is continuously being internalized and either recycled or 
degraded. This seems dependent upon ESCRT, as mutations in ESCRT significantly 
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affect Notch activity (74, 75). Studies have shown that tumor suppressor and ESCRT-II 
component Vps25, regulates Notch activity. When Vps25 is deleted, Notch is improperly 
degraded, which leads to over-proliferation (17). The activity of Vps25 may be similar to 
Chmp1, as its absence leads to loss of growth control, possibly through the regulation of 
Notch or EGF. Additionally, it seems that in order for Delta to be active it is 
monoubiquitinated by ubiquitin ligases, which have been shown to physically interact 
with Delta and promote ubiquitination and internalization (76, 77, 78). Although the 
ESCRT machinery usually mediates degradation and recycling of monoubiquitinated 
transmembrane receptors, it seems that in this case, it works on a transmembrane ligand 
(75). This could be consistent with our over-expression results, if heightened Chmp1 
activity lead to increased ESCRT III activity and therefore increased Delta degradation, 
the result may be a phenotype similar to reduced Delta activity. It has already been 
discussed in the literature that ESCRT machinery plays a very important role in the 
recycling and degradation of activated receptor proteins. The implications of this 
regulation are very important. Without proper ESCRT, cell signaling can be thoroughly 
disrupted, and may lead to considerable problems in the cell such as over-proliferation. 
Chmp1 has been linked to pancreatic cancer in humans. Pancreatic tumors have 
lowered Chmp1expression compared to normal pancreatic cells (22). Another 
characteristic of many pancreatic tumors, which may be a result of Ras mutations, is an 
over-active Epidermal Growth Factor (EGF) pathway (24). Both the EGF receptor and its 
ligands have increased expression and activity in pancreatic tumors (79). Our results 
suggest that Chmp1 negatively regulates EGF signaling, which would be consistent with 
these previous findings, as lowered Chmp1 expression would enhance EGF signaling. 
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Although cancers, pancreatic cancer included, usually have a whole hoard of problems, 
there may be a very important link between EGF signaling and Chmp1 expression. 
 
Section 6: Future Studies 
 We are pretty sure the phenotypes obtained are due to Chmp1 knockdown, as two 
different RNAi lines exhibit similar results. It would be nice to quantify the level of 
Chmp1 knockdown, which may be easy to do with a western blot and a good antibody.  
The UAS-Chmp1 lines need to be balanced. In doing this, we will find out into 
which chromosome the Chmp1 transgene was inserted. Then, to help characterize the 
function of Chmp1, we can obtain more Chmp1 over-expression phenotypes in the 
Drosophila wing. We will also want to over-express Chmp1 while knocking down or 
over-expressing EGF pathway components and possibly Notch pathway components. 
Additionally, at some point we need to check that Chmp1 is in fact being over-expressed, 
and possibly quantify the level of over-expression. This may be easy to do with a western 
blot and a good antibody, or mRNA assays. 
The EGF pathway is quite active in the Drosophila eye. Over-expression and 
knockdown of Chmp1 in the eye will be performed, to investigate whether Chmp1 
functions in the same pathways in the wing as the eye. This will require uncomplicated 
crosses. We have recently obtained a protocol for eye fixation and sectioning that will 
allow for visualization of ommatidial cells. SEM images of the full eye may be useful as 
well. 
As the pUASHM vector has tagged Chmp1 with HM, we should now be able 
visualize the localization of Chmp1 protein within the cells. Wing disc staining and 
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imaging using confocal microscopy could be useful and informative. The salivary glands 
of the Drosophila third instar larvae have polytene chromosomes, which can be easily 
stained and visualized under a light microscope. As previous studies have shown Chmp1 
to localize with condensed chromatin, we can use these Chmp1 HM-tagged lines 
investigate whether the same is true in Drosophila.   
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Bridge to Chapter 2 
 We have shown through Chmp1 knockdown and over-expression that Chmp1 
may regulate the Notch-Delta and EGF signaling pathways. The Notch-Delta and EGF 
pathways are fairly dependent on each other, and actively work together to promote 
proper wing vein formation in the Drosophila wing. However, both Chmp1 knockdown 
and over-expression results in another phenotype that suggests that Chmp1 regulates a 
different and seemingly separate pathway as well, which is known as the Frizzled Planar 
Cell Polarity pathway. The Frizzled Planar Cell Polarity pathway is responsible for 
establishing proper planar cell polarity (PCP) in the Drosophila cuticle. We explored the 
effect of Chmp1 on PCP, and found that Chmp1 may regulate this pathway through a 
PCP protein called Strabismus. 
 
 
 
 
 
 
 
 
 
 
 
 
44 
 
Chapter 2 – Chmp1 and Planar Cell Polarity 
 
Section 1: Introduction 
 Cell polarity is caused by an asymmetrical distribution of molecules in a cell. The 
establishment of cell polarity in organisms is extremely important for cell diversity and 
tissue specialization. During development almost all cells become polarized in some way, 
and in many cases, the polarity of the cells must be correctly coordinated with the 
polarity of the tissue (80, 81). One quite common example of this is planar cell polarity 
(PCP), in which epithelial cells become polarized in a plane of epithelium not only on the 
apical-basal axis, but also within the plane of cells (82). This cell polarity is important for 
the proper function of many tissues, from the sensory hair cells in the vertebrate inner ear 
to hair and feather arrangement in animals (82). PCP has been studied extensively in the 
Drosophila cuticle and many polarity proteins have been identified that are required for 
the process (83). One of the key components for the establishment of cell polarity is a 
conserved pathway called the Frizzled Planar Cell Polarity pathway (Figure 15) (84).  
Some of the significant members of this pathway include Frizzled (Fz), 
Disheveled (Dsh), Prickle (Pk), Van Gogh (Vang, also known as Strabismus [Stbm]), 
Diego (Dgo), and Starry night (Stan, also known as Flamingo [Fmi]). Fz is a seven-pass 
transmembrane receptor which localizes at the distal end of the developing wing cell (85, 
86), Dsh is a cytoplasmic protein and colocalizes with Fz (87, 88), Vang/Stbm is a four 
pass transmembrane protein and is found at the proximal end of the developing wing cell 
(89, 90), Stan/Fmi is a seven-pass membrane protein with cadherin domains and localizes 
both proximally and distally (88, 91, 92), Pk is a cytoplasmic protein which accumulates 
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at the proximal edge (94, 95), and Dgo is a cytoplasmic protein which accumulates at the 
distal and proximal edges (95). The asymmetric distribution of these proteins is important 
for intracellular and extracellular signaling, and proper PCP establishment. Failure to 
appropriately localize of all six of these proteins results in a disruption of PCP.  
 
  
 
 
 
 
 
  
 
 
 
 
In Drosophila melanogaster, PCP is required for proper organization of cuticular 
structures in the adult organism, but has been best characterized in the wing, sensory 
bristles and eye. In the wing, it is required for correct orientation and number of wing 
hairs produced by the wing cells and mutations in any one of the PCP proteins disrupt the 
wing hair polarity. Depending on the mutated protein, a wing hair may be produced in a 
different area of the cell, pointing a different direction, or multiple hairs may be produced 
per cell (83). 
Although the Fz PCP pathway was initially characterized in epithelial structures 
in Drosophila, it seems to be a conserved pathway in vertebrates and is required for many 
diverse processes. Vertebrate PCP was first discovered to be required for convergent 
Figure 15. Frizzled signaling pathway (96). 
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extension movements in during neurulation in Xenopus and zebrafish embryos (97, 98, 
99). There is now evidence that it is also involved in the process of neural tube closure 
(99, 100), cardiovascular development (101) and establishing the precisely aligned 
orientations of sensory hair cells in vertebrate ears (100, 102). 
Strabismus is a transmembrane protein that has been shown to physically interact 
with Fz-PCP pathway proteins Pk, Dgo, and Dsh (90, 103, 104). Recent studies in 
zebrafish show that the PCP protein, Stbm, can physically interact with Chmp1A in a 
yeast two-hybrid screen as well as in a co-immunoprecipitation assay (33). A study done 
by Dr. Maiyon Park at Marshall University School of Medicine showed that loss of Stbm 
activity in zebrafish embryos causes faulty convergent extension
12
. The resulting embryo 
has a short and wide body, opposed to the normal long and narrow body. The same study 
found that loss of Chmp1A activity during zebrafish embryogenesis results in a 
convergent extension phenotype very similar to loss of Stbm, suggesting a physical 
Chmp1A-Stbm interaction that may regulate cell movement. 
 
Section 2. Objective and Hypothesis 
 Section 2.1: Objective 
 There were two objectives of this study. The first objective was to determine if 
Chmp1 regulates planar cell polarity (PCP) in Drosophila by observing the effect of 
knockdown and over-expression. The second objective was to determine if Chmp1 
interacts with PCP protein, Strabismus, in Drosophila. 
                                               
12
 Convergent extension is a process during embryogenesis where cells come together 
(converge) and  lengthen (extend) the body. It only involves the movement of cells, not 
change in cell shape or cell division. 
47 
 
 Section 2.2: Hypothesis 
 We hypothesize that Chmp1 in Drosophila regulates PCP through an interaction 
with PCP protein, Strabismus, like it does in zebrafish. 
 
Section 3: Materials and Methods 
Table 5. Genotypes of fly lines used 
Name Genotype 
Oregon R (wild-type) Oregon R-C 
Chmp1IR/Cy w
1118
; P{GD11219}v21788/CyO 
MS1096-Gal4 w
1118
 P{w
+mW.hs
=GawB}Bx
MS1096 
Vang
TBS42
 b pr cn TBS42/CyO 
en-gal4 P {en2.4-GAL4}e16E 
  
  
Section 4: Results 
 As previous studies in zebrafish have shown a possible Chmp1-Stbm interaction, 
we wanted to see if the same was true for Drosophila. As we already have fly lines 
heterozygously mutant for Stbm, and the Chmp1IR line, this was rather simple. 
In order to test for a Chmp1-Stbm interaction, about 10 Chmp1IR/Cy male flies 
were crossed to 10 MS1096-Gal4; Cy/Sco female virgins. The parent generation was 
moved to a new vial containing fresh food every 2-3 days. From that cross, 10 first 
generation virgin females that were MS1096-Gal4; Chmp1IR/ Sco were then crossed to 
10 Vang
TBS42
/Cy males. The parent flies for this cross were moved to a new vial 
containing fresh food every 2-3 days.  The flies obtained from this cross were cultured 
during their development at 25
o
, 28
o
 and 30
o
.  The flies that were used were those 
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cultured at 28
o
C, as they produced the best phenotypes. Culturing at 25
o
C produces a 
rather weak phenotype, while culturing at 30
o
C, which is the optimal temperature for the 
UAS-Gal4 system, produces very strong Chmp1 phenotypes, resulting in wings in which 
vein and intervein tissues are indistinguishable and rendering PCP phenotypic studies 
rather useless. The wings on the right side of the flies were dissected off and mounted 
dorsally on a microscope slide in GMM. 
Flies heterozygous for stbm (Vang
TBS42
) have a weak dominant phenotype in the 
proximal part of the wing, but mostly exhibit a wild-type wing phenotype (Figure 16A). 
There was no vein overgrowth, and hardly any PCP phenotype was observed. This 
indicates that low Stbm activity is sufficient for proper PCP. Ubiquitous Chmp1 
knockdown in the wing results in wing vein overgrowth (Figure 16B), but no PCP 
phenotypes. This result alone would suggest that PCP is unaffected by Chmp1. However, 
knocking down Chmp1 in wings heterozygous for stbm results in overgrown wing veins 
as well as a PCP phenotype, which includes multiple hairs produced per cell and a change 
in hair polarity (Figure 16C). This result does suggest that Chmp1 and Stbm are 
somehow interacting, as PCP is only disrupted when both of the proteins are less active, 
and PCP is executed properly when Chmp1 and Stbm levels are normal. The PCP 
phenotype observed here is similar to phenotypes observed in wings homozygously 
mutant for stbm, as well as other PCP mutant wings, including Fz (105). Interestingly, the 
most noticeable PCP phenotype in these wings was seen in the wing hairs surrounding 
the wing veins. Usually, wing hairs point toward high Stbm activity (Figure 16C), 
suggesting that the wing veins have lower Stbm than the intervein tissue, but also that 
reduced activity of Stbm is associated with reduced activity of Chmp1. 
49 
 
To test that these results were consequential of and specific to a Chmp1-Stbm 
interaction, Chmp1 was also knocked down with other members of the PCP pathway. 
When Chmp1 is knocked down along with reduced activity of Fz (MS1096-Gal4; UAS-
Chmp1IR; fz
P21
/+) or Pk (MS1096-Gal4; UAS-Chmp1IR/ pk
pk-sple14
), no PCP phenotypes 
are observed. This suggests that the PCP phenotype observed is indeed due to a Chmp1-
Stbm interaction, rather than a Chmp1 interaction with other PCP proteins. 
We also looked at Chmp1 knockdown alone in the wing, both ubiquitously and in 
the posterior half of the wing. To look at ubiquitous Chmp1 knockdown, Chmp1IR/Cy 
females were crossed to MS1096-Gal4; Cy/Sco males. In order to look at Chmp1 
knockdown in the posterior half of the wing, Chmp1IR/Cy virgin females were crossed to 
en-Gal4 males. The parent generation of each cross was moved to a new vial with fresh 
fly food every two to three days, and the first generation was cultured at 25
o
C, 28
o
C, and 
30
o
C. The wings used for this study were those developed at 28
o
C. The wings were 
dissected off of the flies and mounted dorsally on a glass slide in GMM. As we saw 
previously, when Chmp1 was knocked down ubiquitously in the dorsal wing, the result 
was vein overgrowth and no PCP phenotypes were observed (Figure 16B, D). However, 
when Chmp1 is knocked down in only the posterior half of the wing, we do see PCP 
phenotypes, such as doubled hairs and a change in hair polarity, at the boundary of 
Chmp1 knockdown and normal levels Chmp1 expression (Figure 16E). This suggests that 
in order for Chmp1 alone to have an effect on PCP, there must be a gradient of Chmp1 
activity. 
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Figure 16. Chmp1 and Stbm. 
 
A. A wing heterozygous for Stbm (stbm
VangTBS42
) has an apparent wild-type wing B. 
Chmp1 knockdown (MS1096-Gal4; UAS-ChmpIR) results in overgrown wing veins C. A 
wing heterozygous for Stbm, as well as having Chmp1 knockdown (MS1096-Gal4; UAS-
Chmp1IR/stbm
VangTBS42
) results in overgrown wing veins, but also a PCP phenotype as 
hair polarity is abnormal D. Wild-type wing (Oregon R) E. Knockdown of Chmp1 in the 
posterior half of the wing (en-Gal4; UAS-Chmp1IR) results in overgrown wing veins in 
the posterior half of the wing, but also PCP phenotypes such as doubled hairs (circled in 
red) and abnormal hair polarity at the boundary of Chmp1 knockdown. 
 
 
 Unexpectedly, PCP effects were also observed in Chmp1 over-expression wings. 
The over-expression lines that were created, when crossed to MS1096-Gal4, should over-
express Chmp1 ubiquitously in the wing. Nine out of the ten untagged over-expression 
lines resulted in phenotypes indicative of faulty PCP (Figure 17). The PCP effects are not 
as severe as those observed in regional Chmp1 knockdown. 
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Figure 17. Untagged Chmp1 over-expression in the Drosophila wing resulted in PCP 
effects. 
Doubled hairs are indicated in the red circles. All wings were from male adults developed 
at 28
o
C. All images were taken between the L3 and L5 veins, near the PCV and ACV 
(usually missing in these wings). A.) MS1096-Gal4; UAS-Chmp1 5491-2-1M  B.) 
MS1096-Gal4; UAS-Chmp1 5491-2-2M  C.) MS1096-Gal4; UAS-Chmp1 5491-2-3M  D.) 
MS1096-Gal4; UAS-Chmp1 5491-2-4M  E.) MS1096-Gal4; UAS-Chmp1 5491-2-5M  F.) 
MS1096-Gal4; UAS-Chmp1 5491-2-6M  G.) MS1096-Gal4; UAS-Chmp1 5491-2-7M  
H.) MS1096-Gal4; UAS-Chmp1 5491-2-8M  I.) MS1096-Gal4; UAS-Chmp1 5491-2-9M 
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Section 5: Discussion 
The results of this study suggest that there is indeed an interaction between 
Chmp1 and Stbm in Drosophila, and that this interaction is important for the 
establishment of proper PCP. When Chmp1 and Stbm interact in the correct fashion, 
proper PCP is established. However, when the interaction between Chmp1 and Stbm is 
disrupted, PCP is disrupted as well. It is unknown how these proteins are interacting, 
though from previous studies, it seems that the interaction is not permanent, but is short 
lived (33). 
Studies in zebrafish suggest that Chmp1 regulates PCP through an interaction 
with Stbm (33). Phenotypes obtained from Chmp1 knockdown in zebrafish resembled 
stbm mutants, and the same seems true for Drosophila. It is very nice that we see the 
same result in Drosophila as was observed in zebrafish. This suggests that Chmp1 
function is conserved between zebrafish and Drosophila, and it is possible that is 
conserved between other organisms as well.  
Stbm is a transmembrane protein. It has recently been described as a 
transmembrane receptor for Fz extracellular domain (106). It has not been shown that 
Stbm is regulated by ESCRT machinery, nor have any results been published regarding 
regulation of Stbm by ubiquitination. Nevertheless, its receptor capabilities make it a 
potential ESCRT target. Other than being a member of ESCRT, Chmp1 has also been 
implicated in gene silencing. Chmp1 is normally associated with condensed chromatin 
and recruitment of gene silencing proteins, and it is possible that this action of Chmp1 is 
important in the regulation of Stbm, or genes that may regulate Stbm.   
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An interesting result was the way Chmp1 seems to affect hair polarity. When 
Chmp1 was knocked down in a background of Stbm, the strongest effect on hair polarity 
was seen at the wing veins. Specifically, hairs pointed away from the wing vein. 
Typically in the wing, hairs point toward high Stbm activity. This would suggest that 
there is lower Stbm in the wing vein. However, the driver (MS1096-Gal4) that we used 
should drive Chmp1-IR ubiquitously in the wing. If Chmp1 does regulate PCP through 
Stbm, it is strange that ubiquitous Chmp1 knockdown would result in localized reduction 
of Stbm. One possible explanation for this is that wing vein tissue and intervein tissue 
have different requirements for Chmp1, and therefore each tissue is differentially affected 
by Chmp1 knockdown.  
Chmp1 has been linked to pancreatic cancer. Previous studies, as well as our 
studies, suggest that Chmp1 is involved in the regulation of growth. In Drosophila, 
Chmp1 knockdown and over-expression result in what seem to be two differential 
phenotypes: 1) misregulation of growth and 2) planar cell polarity effects. These 
phenotypes may not be as far separated as we originally thought. There are some recent 
reports linking PCP to cancer. One study found that in loss of VANGL2, human 
homologue of Strabismus, promotes migration and invasion in human cancer cells (108). 
Additionally, aberrant activation of the PCP signaling pathway in human cancer cells can 
lead to more malignant phenotypes (109). If PCP is regulated by Chmp1, it is possible 
that Chmp1 misregulation could lead to cancer-related phenotypes such as over-
proliferation or migration, as well as PCP phenotypes, resultant of faulty Fz-PCP 
signaling. 
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Section 6: Future Studies 
 Although in it was found that Chmp1 and Stbm interact in zebrafish, it might be a 
good idea to do an assay to make sure that the same is true in Drosophila. Our results do 
suggest the Chmp1-Stbm interaction, but we still want to be positive. This could be done 
using a yeast two-hybrid assay. Another method, and maybe a more informative one, 
would be a co-immunoprecipitation.  
Now that we have the Chmp1 over-expression lines available we can look at 
Chmp1 over-expression along with reduced activity of Stbm. This simple cross could 
provide more information as to how Chmp1 may be involved with PCP. Additionally, 
one of our over-expression lines has a tagged Chmp1 protein. With some good 
antibodies, we could look at Chmp1 localization, along with Stbm localization, for 
further support of a Chmp1-Stbm interaction. 
We looked at Chmp1 knockdown along with reduced activity of Fz and Pk, but it 
would probably be a good idea to look at Chmp1 knockdown along with reduced activity 
of Fmi, since it is a transmembrane protein.  
It may be interesting to look at Chmp1 and Stbm in the eye of the fly. This would 
be very simple, as we already have some fly lines that drive Gal4 in the eye. The eye is a 
very regular structure, and the establishment of cell polarity by PCP is extremely 
important. This and the regular structure of the eye make the eye good place to study PCP 
in the fly, as small problems become very apparent. 
It would be very nice find out whether Chmp1 regulates Stbm by the ESCRT 
machinery. We could try to find out whether Stbm is ubiquitinated at the membrane. If it 
is, that small bit of evidence would be very suggestive of ESCRT regulation. 
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Final Discussion 
 Our results suggest that Chmp1 regulates three different pathways in the 
Drosophila wing: the Epidermal Growth Factor Pathway, Notch-Delta signaling, and the 
Frizzled Planar Cell Polarity pathway. Our studies of Chmp1 knockdown and EGF 
regulators in the wing indicate that Chmp1 negatively regulates the EGF pathway during 
wing vein development in Drosophila. When we over-express Chmp1 in the wing, we see 
what appears to be faulty Notch-Delta signaling, which is apparent by the “delta” wing 
vein phenotype. Both the EGF pathway and Notch-Delta signaling are very important for 
wing vein development and actively interact to promote proper wing vein size. At this 
point, it is unclear whether Chmp1 regulates one or both of these signaling pathways. It is 
also unclear at what level Chmp1 regulation comes into play. Chmp1 has two major 
functions in the cell: it mediates the degradation of activated receptor proteins through 
ESCRT, but it also is involved in gene silencing in the nucleus. It is possible that 
regulation is at the level of transcription. However, it is most likely that Chmp1 regulates 
these pathways through its ESCRT function. The EGF receptor, the Notch receptor, and 
the Delta ligand are all probably regulated by ESCRT machinery. Thus, if mis-regulation 
of Chmp1 affects ESCRT function, these signaling pathways would be affected. 
 Our studies also suggest that Chmp1 regulates Fz-PCP signaling by an interaction 
with PCP protein, Strabismus.  Strabismus is a transmembrane receptor protein, and 
therefore it is possible that it is regulated by ESCRT machinery as well. Our studies so 
far make it seem as though Chmp1 regulation of EGF/Notch-Delta signaling and PCP is 
separate, since Chmp1 knockdown and over-expression seemed to result in two different 
phenotypes. However, it would be interesting if there was more of a connection than 
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between these pathways than is traditionally thought. In the Drosophila wing, wing veins 
are formed by the EGF pathway. When EGF activators are absent, no wing vein forms, 
which suggests that EGF signaling is absolutely necessary for wing vein formation. 
Interestingly, hair polarity in the wing, which is directed by the Fz-PCP pathway, is often 
affected near the wing veins. A possibility for this wing vein effect on hair polarity is that 
EGF signaling affects PCP signaling. When we knocked down Chmp1while reducing 
Stbm activity, the strongest phenotype was observed at the wing vein, where the hair 
polarity was severely altered. This was an unexpected and rather confusing result. It is 
possible that the change in hair polarity is a result of an interaction of Fz-PCP and EGF 
signaling. There have been some reports of the need for cooperative EGF and Fz-PCP 
signaling to establish cell fate and planar cell polarity (110). It is possible that these 
pathways are interconnected and that each can influence the activity of the other. 
Ultimately, there is still much that is unclear, and further investigation is needed to 
determine exactly how Chmp1 may regulate these pathways. 
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Figure 18. Inserting Chmp1 into pUAST 
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Figure 19. Inserting Chmp1 into pUASHM 
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Source: Berkeley Drosophila Genome Project 
 
 
Figure 20. pOT2 vector 
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Source: Addgene 
 
 
 
 
 
 
 
 
Figure 21. pUAST vector 
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Figure 22. pUASHM vector 
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Source: Stratagene 
Figure 23. pBluescript vector 
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